Suzuken, JP3398000004

Suzuken stock: H1 operating profit falls 20% as sales rise

Published on 11/18/2026 at 03:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Suzuken stock faces margin pressure after higher purchasing and outsourcing costs cut profitability. Full-year revenue and earnings guidance remained unchanged.

Sales Grow as Margins Tighten

  • First-half revenue rose 5.1 percent to 1,281,025 million yen.
  • Higher purchasing and outsourcing costs weighed on operating profit.
  • Full-year revenue and earnings guidance remained unchanged.
Suzuken, JP3398000004, Illustration mit AI erstellt.

Suzuken reported on November 12, 2026, that revenue rose during the first half of the fiscal year ending March 2027, while operating profit declined as purchasing prices and operating costs increased. The interim financial summary showed the company maintained its full-year outlook.

Costs Weigh on Interim Results

Revenue reached 1,281,025 million yen in the six months through September, up 5.1 percent from the prior-year period. Operating profit fell 20.0 percent to 13,561 million yen, while ordinary profit declined 14.9 percent to 15,343 million yen.

Net income attributable to owners of the parent decreased 20.1 percent to 12,974 million yen. Suzuken cited higher purchasing prices and operating expenses, including outsourcing costs, as pressures on profitability.

Guidance Remains Unchanged

Suzuken kept its forecast for the fiscal year ending March 2027 unchanged. It expects revenue of 2,563,000 million yen, operating profit of 31,200 million yen, ordinary profit of 34,300 million yen and net income attributable to owners of the parent of 25,000 million yen.

The pharmaceutical wholesale business remained the main contributor, with first-half revenue of 1,236,309 million yen and segment profit of 12,339 million yen. Logistics increased segment profit, while the digital business and community healthcare and nursing care support reported operating losses.

Business Model and Market Position

Suzuken is based in Nagoya, Japan. It sells prescription medicines, reagents, medical equipment, medical materials and food, and also develops and manufactures medical equipment.

Suzuken Company Facts

  • Company: Suzuken Co., Ltd.
  • ISIN: JP3398000004
  • Ticker: 9987
  • Home exchange: Tokyo Stock Exchange Prime
  • Headquarters: Nagoya, Japan
  • Reporting period: Six months ended September 30, 2026

Japan's Nikkei 225 provides the relevant home-market context for Suzuken stock.

More news and analyses on Suzuken stock.

Disclaimer...
en | JP3398000004 | SUZUKEN | boerse | 70529206 | bgmi